Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
What is a National Research Agency?
di Luca Carra
What is a National Research Agency? Conduct: A National Research Agency is a national and international research funding and coordination body, independent from the relevant ministries. If we look around, almost every country has at least one. Except for Italy, which has now decided to set it up. This is undoubtedly good news, very good news. And let us, at least for a moment, be pleased that our country will also have a technical structure for the orderly management of research funding according to government directives.
